The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Pfizer’s tafamidis to treat patients suffering from transthyretin cardiomyopathy, a rare condition characterised by progressive heart failure. Tafamidis is an investigational […]
Sandoz has secured approval from the European Commission for Zessly (infliximab) in gastroenterological, rheumatological and dermatological diseases. Zessly is approved for use in all indications of the reference medicine including rheumatoid arthritis, adult Crohn’s […]
Swedish drug discovery company Beactica has entered into a three-year extension of its master services agreement with Sanofi. The agreement outlines the legal terms under which Beactica and Sanofi collaborate on the characterization of […]
SMi Reports: With 2 weeks until the 2ndAnnual Pharmaceutical Microbiology West Coast conference, potential attendees are urged to book their place soon, as places are limited. There is less than 2 weeks until SMi’s2nd annual […]
OptiBiotix Health has entered into a five year agreement with Akums Drugs and Pharmaceuticals to exclusively manufacture and supply products featuring OptiBiotix’s cholesterol and blood pressure reducing strain LPLDL in India. The agreement is […]